miRNA profiling of NurOwn®: mesenchymal stem cells secreting neurotrophic factors

per Gothelf, Yael, Kaspi, Haggai, Abramov, Natalie, Aricha, Revital
Publicat a Stem Cell Res Ther (2017)

MiR-375 Promotes Redifferentiation of Adult Human β Cells Expanded In Vitro

per Nathan, Gili, Kredo-Russo, Sharon, Geiger, Tamar, Lenz, Ayelet, Kaspi, Haggai, Hornstein, Eran, Efrat, Shimon
Publicat a PLoS One (2015)

MSC-NTF (NurOwn®) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model

per Kaspi, Haggai, Semo, Jonathan, Abramov, Nathalie, Dekel, Chen, Lindborg, Stacy, Kern, Ralph, Lebovits, Chaim, Aricha, Revital
Publicat a Stem Cell Res Ther (2021)

NurOwn, phase 2, randomized, clinical trial in patients with ALS: Safety, clinical, and biomarker results

per Berry, James D., Cudkowicz, Merit E., Windebank, Anthony J., Staff, Nathan P., Owegi, Margaret, Nicholson, Katherine, McKenna-Yasek, Diane, Levy, Yossef S., Abramov, Natalie, Kaspi, Haggai, Mehra, Munish, Aricha, Revital, Gothelf, Yael, Brown, Robert H.
Publicat a Neurology (2019)